Moreover, Gal-3C, as dominant-negative inhibitor of full-length Gal-3, presented potential anti-tumor activity via inhibiting angiogenesis, reducing tumor growth and metastasis [10, 12, 26, 27]. The gene discussed is LGALS3; the disease is neoplasm.